A clinical trial for GBM treatment using adoptive transfer of human γδ T cells expressing MGMT (ClinicalTrials.gov Identifier: NCT04165941) in combination with temozolomide is currently in progress. The gene discussed is MGMT; the disease is glioblastoma.